Image
On July 12, 2018, people with ALS, advocates, academics, clinicians, and industry panelists participated in moderated discussions exploring key topics in ALS drug development, such as (1) benefit-risk consideration; (2) study design, natural history, recruitment, and (3) retention; and outcome measures, endpoints, and accelerated approval considerations. Audience and online participation was encouraged.
Live Stream and Recording
The ALS Community workshop was live streamed and recorded on Facebook and Youtube. You can view the entire recording below.
